Healthcare giants Johnson & Johnson and AbbVie provide defensive income streams and consistent dividend growth, offering investors a hedge against broader market volatility in 2026.
Johnson & Johnson is highlighted as a resilient Dividend King that has successfully pivoted its business model toward high-growth pharmaceutical and medtech sectors. By focusing on these core areas, the company has achieved 28 products generating over $1 billion in annual revenue and is on track to reach record revenue levels exceeding $100 billion this year.
JNJ offers a dividend yield of 1.9% with an annual payment of $5.36 per share.
The company exited the consumer health business to concentrate exclusively on its pharmaceutical and medtech divisions.
AbbVie demonstrates defensive strength by successfully offsetting the revenue decline from its former blockbuster drug, Humira, with rapid growth in newer products like Skyrizi and Rinvoq. With a diversified portfolio spanning immunology, aesthetics, and neuroscience, the company continues to deliver double-digit revenue growth and maintains a strong commitment to increasing shareholder dividends.
AbbVie provides a dividend yield of 2.7% with an annual payment of $6.92 per share.
The company has successfully transitioned to newer immunology products, Skyrizi and Rinvoq, which are currently delivering impressive revenue growth.
As the S&P 500 faces headwinds from geopolitical instability and inflationary pressures, investors are pivoting toward reliable dividend-paying healthcare stocks. Johnson & Johnson and AbbVie stand out as resilient options, leveraging strong pharmaceutical pipelines and long-term histories of dividend growth to provide portfolio stability.
Healthcare companies often provide essential products and services that maintain steady demand regardless of economic cycles, allowing them to generate consistent revenue and support dividend payments.
A Dividend King is a company that has increased its dividend payout to shareholders for at least 50 consecutive years, signaling strong financial health and management commitment.